Synthetic lethality of KDM1A and mTOR inhibitors: A novel combination therapy for endometrial cancer

被引：0

作者：

Pitta-Venkata, Prabhakar ^{[1
]}

Palacios, Bridgitte ^{[1
]}

Chen, Yihong ^{[1
]}

Viswanadhapalli, Suryavathi ^{[1
]}

Pratap, Uday P. ^{[1
]}

Luo, Yiliao ^{[1
]}

Li, Mengxing ^{[1
]}

Altwegg, Kristin ^{[1
]}

Li, Xiaonan ^{[1
]}

Suzuki, Takayoshi ^{[2
]}

Tekmal, Rajeshwar Rao ^{[1
]}

Kost, Edward ^{[1
]}

Sareddy, Gangadhara Reddy ^{[1
]}

机构：

[1] UT Hlth San Antonio, San Antonio, TX USA

[2] Kyoto Prefectural Univ Med, Kyoto, Japan

来源：

CANCER RESEARCH | 2019年 / 79卷 / 13期

关键词：

D O I：

10.1158/1538-7445.AM2019-280

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

280

引用

页数：2

共 50 条

[21] Novel potent inhibitors of the histone demethylase KDM1A (LSD1), orally active in a murine promyelocitic leukemia model
Trifiro, Paolo
Cappa, Anna
Brambillasca, Silvia
Botrugno, Oronza A.
Cera, Maria Rosaria
Dal Zuffo, Roberto
Dessanti, Paola
Meroni, Giuseppe
Thaler, Florian
Villa, Manuela
Minucci, Saverio
Mercurio, Ciro
Varasi, Mario
Vianello, Paola
FUTURE MEDICINAL CHEMISTRY, 2017, 9 (11) : 1161 - 1174
[22] mTOR inhibitors in cancer therapy
Zaytseva, Yekaterina Y.
Valentino, Joseph D.
Gulhati, Pat
Evers, B. Mark
CANCER LETTERS, 2012, 319 (01) : 1 - 7
[23] Further insights into the SAR of α-substituted cyclopropylamine derivatives as inhibitors of histone demethylase KDM1A
Pieroni, Marco
Annunziato, Giannamaria
Azzali, Elisa
Dessanti, Paola
Mercurio, Ciro
Meroni, Giuseppe
Trifiro, Paolo
Vianello, Paola
Villa, Manuela
Beato, Claudia
Varasi, Mario
Costantino, Gabriele
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 92 : 377 - 386
[24] Novel KDM1A inhibitors induce differentiation and apoptosis of glioma stem cells via unfolded protein response pathway
G R Sareddy
S Viswanadhapalli
P Surapaneni
T Suzuki
A Brenner
R K Vadlamudi
Oncogene, 2017, 36 : 2423 - 2434
[25] KDM1A inhibition increases UVA toxicity and enhances photodynamic therapy efficacy
Mudambi, Shaila
Fitzgerald, Megan
Pera, Paula
Washington, Deschana
Chamberlain, Sarah
Fidrus, Eszter
Hegedus, Csaba
Remenyik, Eva
Shafirstein, Gal
Bellnier, David
Paragh, Gyorgy
PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE, 2023, 39 (03) : 226 - 234
[26] The KDM1A histone demethylase is a promising new target for the epigenetic therapy of medulloblastoma
Pajtler, Kristian W.
Weingarten, Christina
Thor, Theresa
Kunkele, Annette
Heukamp, Lukas C.
Buttner, Reinhard
Suzuki, Takayoshi
Miyata, Naoki
Grotzer, Michael
Rieb, Anja
Sprussel, Annika
Eggert, Angelika
Schramm, Alexander
Schulte, Johannes H.
ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2013, 1
[27] Novel KDM1A inhibitors induce differentiation and apoptosis of glioma stem cells via unfolded protein response pathway
Sareddy, G. R.
Viswanadhapalli, S.
Surapaneni, P.
Suzuki, T.
Brenner, A.
Vadlamudi, R. K.
ONCOGENE, 2017, 36 (17) : 2423 - 2434
[28] The KDM1A histone demethylase is a promising new target for the epigenetic therapy of medulloblastoma
Kristian W Pajtler
Christina Weingarten
Theresa Thor
Annette Künkele
Lukas C Heukamp
Reinhard Büttner
Takayoshi Suzuki
Naoki Miyata
Michael Grotzer
Anja Rieb
Annika Sprüssel
Angelika Eggert
Alexander Schramm
Johannes H Schulte
Acta Neuropathologica Communications, 1
[29] GYS1 inhibition and synthetic lethality with mitochondrial inhibitors in breast cancer
de Heer, Ellen
Zois, Christos E.
Haider, Syed
Ebner, Daniel
Ratcliffe, Andrew
Harris, Adrian
BRITISH JOURNAL OF CANCER, 2019, 121 : 6 - 6
[30] KDM1A/ LSD1 inhibition enhances chemotherapy response in ovarian cancer
Johnson, Jessica D.
Chen, Yihong
Jayamohan, Sridharan
He, Yi
Jamwal, Diksha
Pandey, Neetesh
Kost, Edward
Vadlamudi, Ratna K.
Sareddy, Gangadhara R.
CANCER RESEARCH, 2024, 84 (06)

← 1 2 3 4 5 →